Prime Medicine, Inc. Research And Development Expense

Quick Answer

Prime Medicine, Inc. reported Research And Development Expense of $160.64 million for the year ending 2025.

  • Prime Medicine, Inc. showed an increase of +3.4% in Research And Development Expense from 2024 to 2025.
  • This data is from Prime Medicine, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Prime Medicine, Inc.'s Research And Development Expense has grown by 5,290.5%.
  • Historical annual values: Fiscal year 2025: $160.64 million | Fiscal year 2024: $155.29 million | Fiscal year 2023: $147.91 million | Fiscal year 2022: $86.73 million | Fiscal year 2021: $70.55 million | Fiscal year 2020: $2.98 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: